Morgan Stanley Maintains Overweight on ArcBest, Raises Price Target to $96

Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and raises the price target from $90 to $96.

Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and raises the price target from $90 to $96.

Total
0
Shares
Related Posts